{"disease":{"id":"suicidal-behavior-in-schizophrenia","name":"Suicidal Behavior in Schizophrenia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"clozapine","indication_name":"Suicidal Behavior in Schizophrenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Clozaril","generic_name":"CLOZAPINE","company_name":"Jazz Pharmaceuticals","drug_phase":"marketed","molecular_target":"D2, 5-HT2A","drug_class":"Atypical Antipsychotic [EPC]","quality_score":69,"revenue":null,"mechanism":"Clozapine's efficacy in schizophrenia may be due to its antagonism of D2 and 5-HT2A receptors."},{"drug_id":"clozaril","indication_name":"Suicidal Behavior in Schizophrenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Clozaril","company_name":"Dong Wha Pharmaceutical Co. Ltd.","drug_phase":"phase_1","molecular_target":"Aldehyde oxidase, UDP-glucuronosyltransferase 1-4, 5-hydroxytryptamine receptor 1E","drug_class":"","quality_score":12,"revenue":null,"mechanism":""},{"drug_id":"fazaclo","indication_name":"Suicidal Behavior in Schizophrenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fazaclo","company_name":"Manhattan Psychiatric Center","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, UDP-glucuronosyltransferase 1-4, 5-hydroxytryptamine receptor 1E","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}